WINDWARD BIO GROUP AG (WWB) stock analysis
WWBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$22.64−3.12 (-12.11%)
Close on Nov 18, 2026Market cap –P/E –Yield –
Analysis
Not enough annual history yet
Analysis needs at least two fiscal years of reported financials for Windward Bio.
See a number that looks wrong?